Polyunsaturated fatty acids and the risk of multiple sclerosis

Abstract

Background:

Results from previous studies on polyunsaturated fatty acid (PUFA) intake and multiple sclerosis (MS) risk are conflicting.

Objective:

To prospectively investigate the association between dietary intake of PUFA and MS risk.

Methods:

We followed 80,920 women from Nurses’ Health Study (1984–2004) and 94,511 women from Nurses’ Health Study II (1991–2009) who reported on diet using a validated food frequency questionnaire every 4 years and identified 479 incident MS cases during follow-up. We used Cox regression to estimate hazard ratios (HRs) and 95% confidence intervals (CIs), for the effect of PUFA intake on MS risk adjusting for age, latitude of residence at age 15, ancestry, cigarette smoking, supplemental vitamin D intake, body mass index, and total energy intake.

Results:

Higher intake of total PUFA at baseline was associated with a lower risk of MS (HR top vs bottom quintile: 0.67, 95% CI: 0.49–0.90, p trend = 0.01). Among the specific types of PUFA, only α-linolenic acid (ALA) was inversely associated with MS risk (HR top vs bottom quintile: 0.61, 95% CI: 0.45–0.83, p trend = 0.001). The long-chain fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were not associated with MS risk.

Conclusion:

Low dietary PUFA intake may be another modifiable risk factor for MS.

Keywords

Multiple sclerosis polyunsaturated fatty acids alpha-linolenic acid epidemiology risk factors

Get full access to this article

View all access options for this article.

References

Swank

. Multiple sclerosis: A correlation of its incidence with dietary fat. Am J Med Sci 1950; 220: 421–430.

Swank

Lerstad

Strom

et al . Multiple sclerosis in rural Norway its geographic and occupational incidence in relation to nutrition. N Engl J Med 1952; 246: 722–728.

Thompson

. A biochemical approach to the problem of multiple sclerosis. Proc R Soc Med 1966; 59: 269–276.

Baarnhielm

Olsson

Alfredsson

. Fatty fish intake is associated with decreased occurrence of multiple sclerosis. Mult Scler 2014; 20: 726–732.

Kampman

Wilsgaard

Mellgren

. Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. J Neurol 2007; 254: 471–477.

Ghadirian

Jain

Ducic

et al . Nutritional factors in the aetiology of multiple sclerosis: A case-control study in Montreal, Canada. Int J Epidemiol 1998; 27: 845–852.

Cortese

Riise

Bjornevik

et al . Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study. Mult Scler 2015; 21: 1856–1864.

Berr

Puel

Clanet

et al . Risk factors in multiple sclerosis: A population-based case-control study in Hautes-Pyrenees, France. Acta Neurol Scand 1989; 80: 46–50.

Hoare

Lithander

van der Mei

et al . Higher intake of omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first clinical diagnosis of central nervous system demyelination: Results from the Ausimmune Study. Mult Scler 2016; 22: 884–892.

10.

Zhang

Willett

Hernan

et al . Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women. Am J Epidemiol 2000; 152: 1056–1064.

11.

Giovannucci

Stampfer

Colditz

et al . A comparison of prospective and retrospective assessments of diet in the study of breast cancer. Am J Epidemiol 1993; 137: 502–511.

12.

Rhee

Sampson

Cho

et al . Comparison of methods to account for implausible reporting of energy intake in epidemiologic studies. Am J Epidemiol 2015; 181: 225–233.

13.

Hernan

Olek

Ascherio

. Geographic variation of MS incidence in two prospective studies of US women. Neurology 1999; 53: 1711–1718.

14.

Willett

Sampson

Browne

et al . The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol 1988; 127: 188–199.

15.

Salvini

Hunter

Sampson

et al . Food-based validation of a dietary questionnaire: The effects of week-to-week variation in food consumption. Int J Epidemiol 1989; 18: 858–867.

16.

US Department of Agriculture, Agricultural Research Service, Nutrient Data Laboratory. USDA national nutrient database for standard reference (Release 28), https://ndb.nal.usda.gov/ndb/

17.

Willett

. Nutritional epidemiology. New York: Oxford University Press, 2012.

18.

Garland

Sacks

Colditz

et al . The relation between dietary intake and adipose tissue composition of selected fatty acids in US women. Am J Clin Nutr 1998; 67: 25–30.

19.

Hunter

Rimm

Sacks

et al . Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men. Am J Epidemiol 1992; 135: 418–427.

20.

World Health Organization (WHO). Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: i–xii, 1–253.

21.

Durrleman

Simon

. Flexible regression models with cubic splines. Stat Med 1989; 8: 551–561.

22.

DerSimonian

Laird

. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–188.

23.

Ascherio

Munger

Lunemann

. The initiation and prevention of multiple sclerosis. Nat Rev Neurol 2012; 8: 602–612.

24.

Calder

. Omega-3 polyunsaturated fatty acids and inflammatory processes: Nutrition or pharmacology? Br J Clin Pharmacol 2013; 75: 645–662.

25.

Fleming

Kris-Etherton

. The evidence for alpha-linolenic acid and cardiovascular disease benefits: Comparisons with eicosapentaenoic acid and docosahexaenoic acid. Adv Nutr 2014; 5: 863S–876S.

26.

Micha

Khatibzadeh

Shi

et al . Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: A systematic analysis including 266 country-specific nutrition surveys. BMJ 2014; 348: g2272.

27.

Torkildsen

Wergeland

Bakke

et al . ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): A randomized, double-blind, placebo-controlled trial. Arch Neurol 2012; 69: 1044–1051.

28.

Wergeland

Torkildsen

et al . Polyunsaturated fatty acids in multiple sclerosis therapy. Acta Neurol Scand Suppl 2012; 126: 70–75.

29.

Burdge

. Metabolism of alpha-linolenic acid in humans. Prostaglandins Leukot Essent Fatty Acids 2006; 75: 161–168.

30.

Liou

King

Zibrik

et al . Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. J Nutr 2007; 137: 945–952.

31.

Lopez-Garcia

Schulze

Manson

et al . Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004; 134:1806–1811.

32.

Zhao

Etherton

Martin

et al . Dietary alpha-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects. Am J Clin Nutr 2007; 85: 385–391.

33.

Rallidis

Paschos

Liakos

et al . Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis 2003; 167: 237–242.

34.

Dewell

Marvasti

Harris

et al . Low- and high-dose plant and marine (n-3) fatty acids do not affect plasma inflammatory markers in adults with metabolic syndrome. J Nutr 2011; 141: 2166–2171.

35.

Veldhoen

Hocking

Atkins

et al . TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24: 179–189.

36.

Bettelli

Carrier

Gao

et al . Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235–238.

37.

Poisson

Suhail

Singh

et al . Untargeted plasma metabolomics identifies endogenous metabolite with drug-like properties in chronic animal model of multiple sclerosis. J Biol Chem 2015; 290: 30697–30712.